Vector Science Secures 10-Year cGMP Manufacturing Deal
Mequon, Wisconsin, August 17, 2026 Vector Science and Therapeutics Corp. has entered into an amended and restated exclusive license...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mequon, Wisconsin, August 17, 2026 Vector Science and Therapeutics Corp. has entered into an amended and restated exclusive license...
MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...
RANCHO CORDOVA, CA, March 17, 2026 SK pharmteco has announced the successful completion of a U.S. Food and Drug...
Nazareth, Belgium / Rotterdam, Netherlands | January 12, 2026 — Fagron has completed the acquisition of University Compounding Pharmacy...
REYKJAVÍK, Iceland; LONDON, United Kingdom — December 22, 2025 — Alvotech has announced the European launch of the world’s...
INCHEON, South Korea; ROCKVILLE, Maryland; LONDON — December 21, 2025 — Samsung Biologics, a global contract development and manufacturing...
ANN ARBOR, Mich., Dec. 17, 2025 — Peptinovo Biopharma, in collaboration with Chemelectiva S.r.l., announced a breakthrough manufacturing and...
CHASKA, Minn., December 17, 2025 — Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization (CDMO), has...
RANCHO CUCAMONGA, Calif. — December 15, 2025 — Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration...
EAST HANOVER, N.J. — December 12, 2025 — Novartis, a global innovative medicines company, has officially broken ground on...
